Nexus Minerals (ASX:NXM) has received firm commitments for a capital placement to raise approximately $5.4 million before ...
Neurotech International (ASX:NTI) has dosed the first patient in its pivotal Phase 3 "Beyond Harmony" clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results